| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-20 | 2009-09-30 | N-Q | Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund | Small-Cap Core | | Sold All | -43,250 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-19 | 2009-09-30 | 13F-HR | Mcmillion Capital Management Inc | Institution | 50 | No Change | 0 | 0 % | $843 | $842 | $-1 | -0.11 % | $0 | | | | | | News Article | History of Mcmillion Capital Management Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-19 | 2009-09-30 | 13F-HR/A | Royal Bank Of Canada | Institution | 400 | No Change | 0 | 0 % | $6,744 | $6,736 | $-8 | -0.11 % | $0 | | | | | | News Article | History of Royal Bank Of Canada Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-18 | 2009-09-30 | 13F-HR | Jane Street Holding Llc | Institution | 8,889 | New Holding | 8,889 | 100 % | $154,846 | $149,691 | $-5,156 | -3.32 % | $-5,156 | | | | | | News Article | History of Jane Street Holding Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-18 | 2009-09-30 | N-Q | Mutual Of America Institutional Funds Inc - Small Cap Growth Fund | Small-Cap Growth | 526 | No Compare | | | $9,163 | $8,858 | $-305 | -3.32 % | | | | | | | News Article | History of Mutual Of America Institutional Funds Inc - Small Cap Growth Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-18 | 2009-09-30 | N-Q | Mutual Of America Investment Corp - Small Cap Growth Fund | Small-Cap Growth | 27,845 | No Compare | | | $485,060 | $468,910 | $-16,150 | -3.32 % | | | | | | | News Article | History of Mutual Of America Investment Corp - Small Cap Growth Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-18 | 2009-09-30 | 13F-HR | Royal Bank Of Canada Trust Co Ltd | Institution | 770 | Added More | 350 | 83.33 % | $13,413 | $12,967 | $-447 | -3.32 % | $-203 | | | | | | News Article | History of Royal Bank Of Canada Trust Co Ltd Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-18 | 2009-09-30 | 13F-HR | Timber Hill Llc | No Data | 13,340 | New Holding | 13,340 | 100 % | $232,383 | $224,646 | $-7,737 | -3.32 % | $-7,737 | | | | | | News Article | History of Timber Hill Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | 17,717 | Sold Some | -1,070 | -5.69 % | $308,984 | $298,354 | $-10,630 | -3.44 % | $642 | | | | | | News Article | History of Amvescap Plc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | | Sold All | -43,689 | -100 % | | | | -3.44 % | $26,213 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | 320,106 | Added More | 9,761 | 3.14 % | $5,582,649 | $5,390,585 | $-192,064 | -3.44 % | $-5,857 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Aletheia Research And Management Inc | Institution | 3,107,862 | Added More | 45,345 | 1.48 % | $54,201,113 | $52,336,396 | $-1,864,717 | -3.44 % | $-27,207 | | | | | | News Article | History of Aletheia Research And Management Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | American International Group Inc | Institution | 29,167 | No Change | 0 | 0 % | $508,672 | $491,172 | $-17,500 | -3.44 % | $0 | | | | | | News Article | History of American International Group Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Choate Investment Advisors | Institution | 13,000 | No Change | 0 | 0 % | $226,720 | $218,920 | $-7,800 | -3.44 % | $0 | | | | | | News Article | History of Choate Investment Advisors Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | 495 | Sold Some | -1,522 | -75.45 % | $8,633 | $8,336 | $-297 | -3.44 % | $913 | | | | | | News Article | History of Citadel L P Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Eaton Vance Management | Institution | 252,630 | No Change | 0 | 0 % | $4,405,867 | $4,254,289 | $-151,578 | -3.44 % | $0 | | | | | | News Article | History of Eaton Vance Management Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fifth Third Bancorp | Institution | | Sold All | -40 | -100 % | | | | -3.44 % | $24 | | | | | | News Article | History of Fifth Third Bancorp Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fmr Corp | Institution | 6,259,209 | Added More | 11,401 | 0.18 % | $109,160,605 | $105,405,080 | $-3,755,525 | -3.44 % | $-6,841 | | | | | | News Article | History of Fmr Corp Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ing Groep Nv | Institution | 14,200 | Added More | 2,500 | 21.36 % | $247,648 | $239,128 | $-8,520 | -3.44 % | $-1,500 | | | | | | News Article | History of Ing Groep Nv Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Leuthold Weeden Capital Management Llc | Institution | | Sold All | -212,358 | -100 % | | | | -3.44 % | $127,415 | | | | | | News Article | History of Leuthold Weeden Capital Management Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Madison Square Investors Llc | No Data | 29,688 | Sold Some | -12,319 | -29.32 % | $517,759 | $499,946 | $-17,813 | -3.44 % | $7,391 | | | | | | News Article | History of Madison Square Investors Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 1,936,873 | Added More | 29,933 | 1.56 % | $33,779,065 | $32,616,941 | $-1,162,124 | -3.44 % | $-17,960 | | | | | | News Article | History of Morgan Stanley Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 448,430 | Added More | 48,268 | 12.06 % | $7,820,619 | $7,551,561 | $-269,058 | -3.44 % | $-28,961 | | | | | | News Article | History of Northern Trust Corp Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Oppenheimer Funds Inc | Institution | 1,201,000 | Sold Some | -110,250 | -8.40 % | $20,945,440 | $20,224,840 | $-720,600 | -3.44 % | $66,150 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Perceptive Advisors Llc | Institution | | Sold All | -200,000 | -100 % | | | | -3.44 % | $120,000 | | | | | | News Article | History of Perceptive Advisors Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Perimeter Capital Partners Llc | Institution | 280,142 | Added More | 17,118 | 6.50 % | $4,885,676 | $4,717,591 | $-168,085 | -3.44 % | $-10,271 | | | | | | News Article | History of Perimeter Capital Partners Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Rbc Dominion Securities Inc | Institution | 500 | No Change | 0 | 0 % | $8,720 | $8,420 | $-300 | -3.44 % | $0 | | | | | | News Article | History of Rbc Dominion Securities Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Shaw D E And Co Inc | Institution | | Sold All | -99,924 | -100 % | | | | -3.44 % | $59,954 | | | | | | News Article | History of Shaw D E And Co Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ubs Global Asset Management Americas Inc | Institution | 106,200 | No Change | 0 | 0 % | $1,852,128 | $1,788,408 | $-63,720 | -3.44 % | $0 | | | | | | News Article | History of Ubs Global Asset Management Americas Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 500 | Sold Some | -1,000 | -66.66 % | $8,720 | $8,420 | $-300 | -3.44 % | $600 | | | | | | News Article | History of Us Bancorp De Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wellington Management Co Llp | Institution | | Sold All | -79,433 | -100 % | | | | -3.44 % | $47,660 | | | | | | News Article | History of Wellington Management Co Llp Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | 9,883 | Sold Some | -3,934 | -28.47 % | $169,691 | $166,430 | $-3,261 | -1.92 % | $1,298 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Axa | Institution | 421,482 | Added More | 17,970 | 4.45 % | $7,236,846 | $7,097,757 | $-139,089 | -1.92 % | $-5,930 | | | | | | News Article | History of Axa Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 5,660 | Sold Some | -22,227 | -79.70 % | $97,182 | $95,314 | $-1,868 | -1.92 % | $7,335 | | | | | | News Article | History of Barclays Plc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bnp Paribas Arbitrage Sa | Institution | 16,184 | New Holding | 16,184 | 100 % | $277,879 | $272,539 | $-5,341 | -1.92 % | $-5,341 | | | | | | News Article | History of Bnp Paribas Arbitrage Sa Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Capital One Financial Corp | Institution | 2,724 | Sold Some | -520 | -16.02 % | $46,771 | $45,872 | $-899 | -1.92 % | $172 | | | | | | News Article | History of Capital One Financial Corp Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Dekabank Deutsche Girozentrale | No Data | 33,300 | No Change | 0 | 0 % | $571,761 | $560,772 | $-10,989 | -1.92 % | $0 | | | | | | News Article | History of Dekabank Deutsche Girozentrale Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Diamondback Capital Management Llc | Institution | 74,000 | New Holding | 74,000 | 100 % | $1,270,580 | $1,246,160 | $-24,420 | -1.92 % | $-24,420 | | | | | | News Article | History of Diamondback Capital Management Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Gartmore Mutual Fund Capital Trust | Institution | 1,284 | Sold Some | -56,129 | -97.76 % | $22,046 | $21,623 | $-424 | -1.92 % | $18,523 | | | | | | News Article | History of Gartmore Mutual Fund Capital Trust Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 94,955 | Sold Some | -257 | -0.26 % | $1,630,377 | $1,599,042 | $-31,335 | -1.92 % | $85 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 96,258 | Sold Some | -88,036 | -47.76 % | $1,652,750 | $1,620,985 | $-31,765 | -1.92 % | $29,052 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Hambrecht And Quist Capital Management Llc | Institution | 165,506 | Added More | 122,806 | 287.60 % | $2,841,738 | $2,787,121 | $-54,617 | -1.92 % | $-40,526 | | | | | | News Article | History of Hambrecht And Quist Capital Management Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Los Angeles Capital Management And Equity Research Inc | Institution | 24,938 | New Holding | 24,938 | 100 % | $428,185 | $419,956 | $-8,230 | -1.92 % | $-8,230 | | | | | | News Article | History of Los Angeles Capital Management And Equity Research Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Managed Account Advisors Llc | Institution | 21,866 | Added More | 21,489 | 5700.00 % | $375,439 | $368,223 | $-7,216 | -1.92 % | $-7,091 | | | | | | News Article | History of Managed Account Advisors Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Martingale Asset Management L P | Institution | 16,100 | Sold Some | -10,700 | -39.92 % | $276,437 | $271,124 | $-5,313 | -1.92 % | $3,531 | | | | | | News Article | History of Martingale Asset Management L P Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | New York State Common Retirement Fund | Institution | 12,362 | No Change | 0 | 0 % | $212,256 | $208,176 | $-4,079 | -1.92 % | $0 | | | | | | News Article | History of New York State Common Retirement Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Oak Hill Platinum Partners Llc | Institution | | Sold All | -9,090 | -100 % | | | | -1.92 % | $3,000 | | | | | | News Article | History of Oak Hill Platinum Partners Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Plante Moran Financial Advisors Ltd Partnership | Institution | | Sold All | -750 | -100 % | | | | -1.92 % | $248 | | | | | | News Article | History of Plante Moran Financial Advisors Ltd Partnership Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Price T Rowe Associates Inc | Institution | 66,500 | Added More | 17,100 | 34.61 % | $1,141,805 | $1,119,860 | $-21,945 | -1.92 % | $-5,643 | | | | | | News Article | History of Price T Rowe Associates Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Capital Markets Arbitrage S A | Institution | | Sold All | -970 | -100 % | | | | -1.92 % | $320 | | | | | | News Article | History of Rbc Capital Markets Arbitrage S A Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 17,476 | Sold Some | -8,450 | -32.59 % | $300,063 | $294,296 | $-5,767 | -1.92 % | $2,789 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Private Counsel Inc | Institution | 134,683 | Added More | 44,166 | 48.79 % | $2,312,507 | $2,268,062 | $-44,445 | -1.92 % | $-14,575 | | | | | | News Article | History of Rbc Private Counsel Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Private Counsel Usa Inc | Institution | 4,847 | Added More | 692 | 16.65 % | $83,223 | $81,623 | $-1,600 | -1.92 % | $-228 | | | | | | News Article | History of Rbc Private Counsel Usa Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Renaissance Technologies Corp | Institution | 70,200 | Sold Some | -82,800 | -54.11 % | $1,205,334 | $1,182,168 | $-23,166 | -1.92 % | $27,324 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 1,404,880 | Sold Some | -93,670 | -6.25 % | $24,121,790 | $23,658,179 | $-463,610 | -1.92 % | $30,911 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Allianz Global Investors Of America L P | Institution | | Sold All | -15,831 | -100 % | | | | -3.21 % | $8,865 | | | | | | News Article | History of Allianz Global Investors Of America L P Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Bank Of America Corp | Institution | 76,727 | Added More | 213 | 0.27 % | $1,335,050 | $1,292,083 | $-42,967 | -3.21 % | $-119 | | | | | | News Article | History of Bank Of America Corp Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 2,203,747 | Added More | 165,992 | 8.14 % | $38,345,198 | $37,111,099 | $-1,234,098 | -3.21 % | $-92,956 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Credit Suisse | Institution | 10,455 | New Holding | 10,455 | 100 % | $181,917 | $176,062 | $-5,855 | -3.21 % | $-5,855 | | | | | | News Article | History of Credit Suisse Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Edgewood Management Co | Institution | 20,000 | No Change | 0 | 0 % | $348,000 | $336,800 | $-11,200 | -3.21 % | $0 | | | | | | News Article | History of Edgewood Management Co Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Ing Investment Management Co | Institution | 14,200 | Added More | 2,500 | 21.36 % | $247,080 | $239,128 | $-7,952 | -3.21 % | $-1,400 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 106,999 | Added More | 37,971 | 55.00 % | $1,861,783 | $1,801,863 | $-59,919 | -3.21 % | $-21,264 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 35,968 | Added More | 3,305 | 10.11 % | $625,843 | $605,701 | $-20,142 | -3.21 % | $-1,851 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 17,072 | Added More | 4,853 | 39.71 % | $297,053 | $287,492 | $-9,560 | -3.21 % | $-2,718 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Inc | Institution | 112,245 | Added More | 38,945 | 53.13 % | $1,953,063 | $1,890,206 | $-62,857 | -3.21 % | $-21,809 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Qa3 Financial Llc | No Data | | Sold All | -65 | -100 % | | | | -3.21 % | $36 | | | | | | News Article | History of Qa3 Financial Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Russell Frank Co | Institution | 300 | No Change | 0 | 0 % | $5,220 | $5,052 | $-168 | -3.21 % | $0 | | | | | | News Article | History of Russell Frank Co Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Sands Capital Management Llc | Institution | 121,700 | Added More | 1,700 | 1.41 % | $2,117,580 | $2,049,428 | $-68,152 | -3.21 % | $-952 | | | | | | News Article | History of Sands Capital Management Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | 9,267 | Sold Some | -28,875 | -75.70 % | $161,246 | $156,056 | $-5,190 | -3.21 % | $16,170 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | United Services Automobile Association | Institution | | Sold All | -15,354 | -100 % | | | | -3.21 % | $8,598 | | | | | | News Article | History of United Services Automobile Association Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Virginia Retirement Systems Et Al | Institution | 28,900 | No Change | 0 | 0 % | $502,860 | $486,676 | $-16,184 | -3.21 % | $0 | | | | | | News Article | History of Virginia Retirement Systems Et Al Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-12 | 2009-08-31 | N-CSR | Satuit Capital Management Trust - Satuit Capital Small Cap Fund | No Data | 950 | New Holding | 950 | 100 % | $16,530 | $15,998 | $-532 | -3.21 % | $-532 | | | | | | News Article | History of Satuit Capital Management Trust - Satuit Capital Small Cap Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | American Century Companies Inc | Institution | 55,541 | Added More | 3,031 | 5.77 % | $863,663 | $935,310 | $71,648 | 8.29 % | $3,910 | | | | | | News Article | History of American Century Companies Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Citigroup Inc | Institution | | Sold All | -19,245 | -100 % | | | | 8.29 % | $-24,826 | | | | | | News Article | History of Citigroup Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Clarivest Asset Management Llc | Institution | | Sold All | -12,100 | -100 % | | | | 8.29 % | $-15,609 | | | | | | News Article | History of Clarivest Asset Management Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Comerica Bank | Institution | 26,810 | Sold Some | -25,229 | -48.48 % | $416,896 | $451,480 | $34,585 | 8.29 % | $-32,545 | | | | | | News Article | History of Comerica Bank Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Elefante Michael B | Institution | 12,750 | Added More | 3,200 | 33.50 % | $198,263 | $214,710 | $16,448 | 8.29 % | $4,128 | | | | | | News Article | History of Elefante Michael B Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Glenmede Trust Co Na | Institution | | Sold All | -450 | -100 % | | | | 8.29 % | $-581 | | | | | | News Article | History of Glenmede Trust Co Na Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Highbridge Capital Management Llc | Institution | | Sold All | -21,843 | -100 % | | | | 8.29 % | $-28,177 | | | | | | News Article | History of Highbridge Capital Management Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | J P Morgan Chase And Co | Institution | 16,159 | Added More | 3,238 | 25.05 % | $251,272 | $272,118 | $20,845 | 8.29 % | $4,177 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 67,674 | Added More | 34,443 | 103.64 % | $1,052,331 | $1,139,630 | $87,299 | 8.29 % | $44,431 | | | | | | News Article | History of Ubs Ag Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-10 | 2009-08-31 | N-CSRS | Morgan Stanley Special Growth Fund - None | Specialty & Misc | 27,908 | Sold Some | -1,772 | -5.97 % | $433,969 | $469,971 | $36,001 | 8.29 % | $-2,286 | | | | | | News Article | History of Morgan Stanley Special Growth Fund - None Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Cadence Capital Management Llc | Institution | 257,190 | Added More | 21,940 | 9.32 % | $4,066,174 | $4,331,080 | $264,906 | 6.51 % | $22,598 | | | | | | News Article | History of Cadence Capital Management Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Lee Munder Capital Group Llc | No Data | 50,698 | No Compare | | | $801,535 | $853,754 | $52,219 | 6.51 % | | | | | | | News Article | History of Lee Munder Capital Group Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR/A | Baird Robert W And Co Inc | Institution | 17,605 | Sold Some | -615 | -3.37 % | $284,321 | $296,468 | $12,147 | 4.27 % | $-424 | | | | | | News Article | History of Baird Robert W And Co Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Copper Rock Capital Partners Llc | Institution | 406,192 | New Holding | 406,192 | 100 % | $6,560,001 | $6,840,273 | $280,272 | 4.27 % | $280,272 | | | | | | News Article | History of Copper Rock Capital Partners Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metlife Securities Inc | Institution | | Sold All | -96 | -100 % | | | | 4.27 % | $-66 | | | | | | News Article | History of Metlife Securities Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metropolitan Life Insurance Co | Institution | 32,272 | No Change | 0 | 0 % | $521,193 | $543,460 | $22,268 | 4.27 % | $0 | | | | | | News Article | History of Metropolitan Life Insurance Co Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | 56 | Sold Some | -690 | -92.49 % | $904 | $943 | $39 | 4.27 % | $-476 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Schwab Charles Investment Management Inc | Institution | 67,200 | No Change | 0 | 0 % | $1,085,280 | $1,131,648 | $46,368 | 4.27 % | $0 | | | | | | News Article | History of Schwab Charles Investment Management Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Synovus Financial Corp | Institution | 305 | No Change | 0 | 0 % | $4,926 | $5,136 | $210 | 4.27 % | $0 | | | | | | News Article | History of Synovus Financial Corp Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 82,367 | Sold Some | -190 | -0.23 % | $1,330,227 | $1,387,060 | $56,833 | 4.27 % | $-131 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 207,090 | Sold Some | -62,277 | -23.11 % | $3,344,504 | $3,487,396 | $142,892 | 4.27 % | $-42,971 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Bank Of Hawaii | Institution | | Sold All | -6,500 | -100 % | | | | 2.55 % | $-2,730 | | | | | | News Article | History of Bank Of Hawaii Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Parametric Portfolio Associates | Institution | 31,318 | Added More | 698 | 2.27 % | $514,242 | $527,395 | $13,154 | 2.55 % | $293 | | | | | | News Article | History of Parametric Portfolio Associates Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Proshare Advisors Llc | Institution | 9,543 | Sold Some | -4,608 | -32.56 % | $156,696 | $160,704 | $4,008 | 2.55 % | $-1,935 | | | | | | News Article | History of Proshare Advisors Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Value Line Inc | Institution | 33,600 | No Change | 0 | 0 % | $551,712 | $565,824 | $14,112 | 2.55 % | $0 | | | | | | News Article | History of Value Line Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Loring Wolcott And Coolidge Fiduciary Advisors | Institution | 31,400 | No Change | 0 | 0 % | $547,302 | $528,776 | $-18,526 | -3.38 % | $0 | | | | | | News Article | History of Loring Wolcott And Coolidge Fiduciary Advisors Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Symphony Asset Management Llc | Institution | 462,609 | Sold Some | -106,630 | -18.73 % | $8,063,275 | $7,790,336 | $-272,939 | -3.38 % | $62,912 | | | | | | News Article | History of Symphony Asset Management Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-04 | 2009-08-31 | N-CSR | Ssga Funds - Ssga Enhanced Small Cap Fund | Small-Cap Core | 600 | Sold Some | -600 | -50.00 % | $10,458 | $10,104 | $-354 | -3.38 % | $354 | | | | | | News Article | History of Ssga Funds - Ssga Enhanced Small Cap Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Ixis Asset Management Advisors L P | Institution | 260,606 | Added More | 66,790 | 34.46 % | $4,597,090 | $4,388,605 | $-208,485 | -4.53 % | $-53,432 | | | | | | News Article | History of Ixis Asset Management Advisors L P Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | M And T Bank Corp | Institution | 3,600 | No Change | 0 | 0 % | $63,504 | $60,624 | $-2,880 | -4.53 % | $0 | | | | | | News Article | History of M And T Bank Corp Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Health Care Portfolio | Health/Biotech | 181,200 | No Change | 0 | 0 % | $3,096,708 | $3,051,408 | $-45,300 | -1.46 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Health Care Portfolio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Medical Delivery Portfolio | Health/Biotech | 29,300 | No Change | 0 | 0 % | $500,737 | $493,412 | $-7,325 | -1.46 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Medical Delivery Portfolio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Technology Portfolio | Science & Tech | 158,500 | New Holding | 158,500 | 100 % | $2,708,765 | $2,669,140 | $-39,625 | -1.46 % | $-39,625 | | | | | | News Article | History of Fidelity Select Portfolios - Technology Portfolio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR/A | Perkins Capital Management Inc | Institution | 21,950 | Sold Some | -3,600 | -14.09 % | $374,028 | $369,638 | $-4,390 | -1.17 % | $720 | | | | | | News Article | History of Perkins Capital Management Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Advisor Series I - Growth Opportunities Fund | Large-Cap Core | 1,400 | Added More | 200 | 16.66 % | $23,856 | $23,576 | $-280 | -1.17 % | $-40 | | | | | | News Article | History of Fidelity Advisor Series I - Growth Opportunities Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Advisor Series I - Large Cap Fund | Large-Cap Core | | Sold All | -154,200 | -100 % | | | | -1.17 % | $30,840 | | | | | | News Article | History of Fidelity Advisor Series I - Large Cap Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock | Specialty & Misc | 1,641 | No Compare | | | $27,963 | $27,634 | $-328 | -1.17 % | | | | | | | News Article | History of Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-CSRS | Fidelity Commonwealth Trust Ii - Fidelity Small Cap Enhanced Index Fund | Small-Cap Core | 11,600 | Sold Some | -3,105 | -21.11 % | $197,664 | $195,344 | $-2,320 | -1.17 % | $621 | | | | | | News Article | History of Fidelity Commonwealth Trust Ii - Fidelity Small Cap Enhanced Index Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Mt Vernon Street Trust - Fidelity Aggressive Growth Fund | Multi-Cap Growth | | Sold All | -331,641 | -100 % | | | | -1.17 % | $66,328 | | | | | | News Article | History of Fidelity Mt Vernon Street Trust - Fidelity Aggressive Growth Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Securities Fund - Agressive Growth Fund | Global Small/Mid-Cap Growth | 5,000 | New Holding | 5,000 | 100 % | $85,200 | $84,200 | $-1,000 | -1.17 % | $-1,000 | | | | | | News Article | History of Fidelity Securities Fund - Agressive Growth Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-CSR | Vanguard World Fund - Vanguard Health Care Index Fund | Health/Biotech | 16,068 | New Holding | 16,068 | 100 % | $273,799 | $270,585 | $-3,214 | -1.17 % | $-3,214 | | | | | | News Article | History of Vanguard World Fund - Vanguard Health Care Index Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 353,379 | Sold Some | -1,800 | -0.50 % | $6,155,862 | $5,950,902 | $-204,960 | -3.32 % | $1,044 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Cornerstone Strategy Fund | Specialty & Misc | | Sold All | -2,109 | -100 % | | | | -3.32 % | $1,223 | | | | | | News Article | History of Usaa Mutual Funds Trust - Cornerstone Strategy Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | | Sold All | -545 | -100 % | | | | -3.32 % | $316 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Small Cap Index Fund | Small-Cap Core | 29,167 | New Holding | 29,167 | 100 % | $508,089 | $491,172 | $-16,917 | -3.32 % | $-16,917 | | | | | | News Article | History of Valic Co I - Small Cap Index Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-28 | 2009-09-30 | 13F-HR | Fidgeon Timothy F | Institution | 12,690 | Added More | 1,710 | 15.57 % | $215,857 | $213,700 | $-2,157 | -0.99 % | $-291 | | | | | | News Article | History of Fidgeon Timothy F Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-27 | 2009-09-30 | 13F-HR | Rothschild Capital Management Llc | No Data | 235,775 | New Holding | 235,775 | 100 % | $4,222,730 | $3,970,451 | $-252,279 | -5.97 % | $-252,279 | | | | | | News Article | History of Rothschild Capital Management Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-26 | 2009-09-30 | 13F-HR | Capital Advisors Inc | Institution | 142,280 | Added More | 2,230 | 1.59 % | $2,539,698 | $2,395,995 | $-143,703 | -5.65 % | $-2,252 | | | | | | News Article | History of Capital Advisors Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-26 | 2009-08-31 | N-Q | Claymore Exchange Traded Fund Trust - Claymoremorningstar Services Super Sector Index Etf | Specialty & Misc | 16 | No Change | 0 | 0 % | $286 | $269 | $-16 | -5.65 % | $0 | | | | | | News Article | History of Claymore Exchange Traded Fund Trust - Claymoremorningstar Services Super Sector Index Etf Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-26 | 2009-06-30 | 13F-HR/A | Ameriprise Financial Inc | Institution | 13,817 | Added More | 4,035 | 41.24 % | $246,633 | $232,678 | $-13,955 | -5.65 % | $-4,075 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Apex Capital Management | Institution | 48,741 | Added More | 9,475 | 24.13 % | $925,104 | $820,798 | $-104,306 | -11.27 % | $-20,277 | | | | | | News Article | History of Apex Capital Management Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Group Ltd | Institution | 13,100 | No Change | 0 | 0 % | $248,638 | $220,604 | $-28,034 | -11.27 % | $0 | | | | | | News Article | History of Blackrock Group Ltd Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | | Sold All | -11,745 | -100 % | | | | -11.27 % | $25,134 | | | | | | News Article | History of Blackrock Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 106,652 | Added More | 20,624 | 23.97 % | $2,024,255 | $1,796,020 | $-228,235 | -11.27 % | $-44,135 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 761,655 | Sold Some | -20,014 | -2.56 % | $14,387,663 | $12,826,270 | $-1,561,393 | -10.85 % | $41,029 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | State Board Of Administration Of Florida Retirement System | Institution | 54,116 | Added More | 13,224 | 32.33 % | $1,022,251 | $911,313 | $-110,938 | -10.85 % | $-27,109 | | | | | | News Article | History of State Board Of Administration Of Florida Retirement System Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Public Employees Retirement Association Of Colorado | Institution | 41,100 | No Change | 0 | 0 % | $792,408 | $692,124 | $-100,284 | -12.65 % | $0 | | | | | | News Article | History of Public Employees Retirement Association Of Colorado Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Teachers Retirement System Of The State Of Kentucky | Institution | | Sold All | -8,300 | -100 % | | | | -12.65 % | $20,252 | | | | | | News Article | History of Teachers Retirement System Of The State Of Kentucky Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Puzo Michael J | Institution | 26,522 | Added More | 3,232 | 13.87 % | $542,640 | $446,630 | $-96,010 | -17.69 % | $-11,700 | | | | | | News Article | History of Puzo Michael J Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-19 | 2009-09-30 | 13F-HR | Strs Ohio | Institution | 72,300 | No Change | 0 | 0 % | $1,479,258 | $1,217,532 | $-261,726 | -17.69 % | $0 | | | | | | News Article | History of Strs Ohio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Public Employees Retirement System Of Ohio | Institution | 53,248 | No Change | 0 | 0 % | $1,121,935 | $896,696 | $-225,239 | -20.07 % | $0 | | | | | | News Article | History of Public Employees Retirement System Of Ohio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-09 | 2009-07-31 | N-CSR | Advisors Inner Circle Fund Ii - Growth Fund | Small-Cap Growth | 90,150 | Added More | 31,660 | 54.12 % | $1,976,088 | $1,518,126 | $-457,962 | -23.17 % | $-160,833 | | | | | | News Article | History of Advisors Inner Circle Fund Ii - Growth Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-08 | 2009-09-30 | 13F-HR | Rhumbline Advisers | Institution | 50,339 | Sold Some | -975 | -1.90 % | $1,085,812 | $847,709 | $-238,103 | -21.92 % | $4,612 | | | | | | News Article | History of Rhumbline Advisers Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund | Health/Biotech | 14,000 | Added More | 7,000 | 100.00 % | $298,200 | $235,760 | $-62,440 | -20.93 % | $-31,220 | | | | | | News Article | History of Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii - Fidelity Advisor Health Care Fund | Health/Biotech | 104,274 | Added More | 52,137 | 100.00 % | $2,221,036 | $1,755,974 | $-465,062 | -20.93 % | $-232,531 | | | | | | News Article | History of Fidelity Advisor Series Vii - Fidelity Advisor Health Care Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Alliancebernstein Global Technology Fund Inc - Alliancebernstein Global Technology Fund Inc | Science & Tech | 249,500 | Added More | 1,300 | 0.52 % | $5,381,715 | $4,201,580 | $-1,180,135 | -21.92 % | $-6,149 | | | | | | News Article | History of Alliancebernstein Global Technology Fund Inc - Alliancebernstein Global Technology Fund Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Pacific Capital Funds - Small Cap Fund | Small-Cap Value | | Sold All | -6,500 | -100 % | | | | -21.92 % | $30,745 | | | | | | News Article | History of Pacific Capital Funds - Small Cap Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | 545 | New Holding | 545 | 100 % | $11,756 | $9,178 | $-2,578 | -21.92 % | $-2,578 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Value Fund | Multi-Cap Value | | Sold All | -12,500 | -100 % | | | | -21.92 % | $59,125 | | | | | | News Article | History of Usaa Mutual Funds Trust - Value Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-10-01 | 2009-09-30 | 13F-HR | Anderson Hoagland And Co | Institution | 113,549 | No Change | 0 | 0 % | $2,445,845 | $1,912,165 | $-533,680 | -21.81 % | $0 | | | | | | News Article | History of Anderson Hoagland And Co Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | American Century Mutual Funds Inc - New Opportunities Fund | Small-Cap Growth | 12,705 | New Holding | 12,705 | 100 % | $294,629 | $213,952 | $-80,677 | -27.38 % | $-80,677 | | | | | | News Article | History of American Century Mutual Funds Inc - New Opportunities Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | American Century Mutual Funds Inc - New Opportunities Ii | Small-Cap Growth | 42,818 | New Holding | 42,818 | 100 % | $992,949 | $721,055 | $-271,894 | -27.38 % | $-271,894 | | | | | | News Article | History of American Century Mutual Funds Inc - New Opportunities Ii Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Core Equity Portfolio | International Small-Mid-Cap Value | 35,433 | No Change | 0 | 0 % | $821,691 | $596,692 | $-225,000 | -27.38 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Core Equity Portfolio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio | No Data | 8,655 | No Change | 0 | 0 % | $200,709 | $145,750 | $-54,959 | -27.38 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio | No Data | 400 | No Change | 0 | 0 % | $9,276 | $6,736 | $-2,540 | -27.38 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Capital Trust - Fidelity Small Cap Independence Fund | Small-Cap Core | 64,600 | No Change | 0 | 0 % | $1,498,074 | $1,087,864 | $-410,210 | -27.38 % | $0 | | | | | | News Article | History of Fidelity Capital Trust - Fidelity Small Cap Independence Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Fidelity Commonwealth Trust - Fidelity Large Cap Stock Fund | Large-Cap Core | 56,300 | New Holding | 56,300 | 100 % | $1,305,597 | $948,092 | $-357,505 | -27.38 % | $-357,505 | | | | | | News Article | History of Fidelity Commonwealth Trust - Fidelity Large Cap Stock Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Ishares Trust - Ishares Morningstar Small Growth Index Fund | Small-Cap Growth | 11,697 | Added More | 1,983 | 20.41 % | $271,253 | $196,977 | $-74,276 | -27.38 % | $-12,592 | | | | | | News Article | History of Ishares Trust - Ishares Morningstar Small Growth Index Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Jnl Investors Series Trust - Jackson Perspective Index 5 Fund | Specialty & Misc | 364 | No Change | 0 | 0 % | $8,441 | $6,130 | $-2,311 | -27.38 % | $0 | | | | | | News Article | History of Jnl Investors Series Trust - Jackson Perspective Index 5 Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Vanguard Explorer Fund - Vanguard Explorer Fund | Small-Cap Growth | | Sold All | -119,200 | -100 % | | | | -27.38 % | $756,920 | | | | | | News Article | History of Vanguard Explorer Fund - Vanguard Explorer Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund | Small-Cap Core | | Sold All | -1,200 | -100 % | | | | -27.81 % | $7,788 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund | Small-Cap Core | | Sold All | -2,200 | -100 % | | | | -27.81 % | $14,278 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Old Westbury Funds Inc - International Fund | International Multi-Cap Core | 2,700 | No Change | 0 | 0 % | $62,991 | $45,468 | $-17,523 | -27.81 % | $0 | | | | | | News Article | History of Old Westbury Funds Inc - International Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange-Traded Fund Trust Ii - Powershares Global Biotech Portfolio | No Data | 938 | Added More | 60 | 6.83 % | $21,884 | $15,796 | $-6,088 | -27.81 % | $-389 | | | | | | News Article | History of Powershares Exchange-Traded Fund Trust Ii - Powershares Global Biotech Portfolio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-21 | 2009-06-30 | 13F-HR/A | Eaton Vance Management | Institution | 252,630 | New Holding | 252,630 | 100 % | $5,876,174 | $4,254,289 | $-1,621,885 | -27.60 % | $-1,621,885 | | | | | | News Article | History of Eaton Vance Management Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-17 | 2009-07-31 | N-Q | Rydex Etf Trust - Rydex Inverse Russell 2000 Etf | Specialty & Misc | 770 | New Holding | 770 | 100 % | $18,187 | $12,967 | $-5,221 | -28.70 % | $-5,221 | | | | | | News Article | History of Rydex Etf Trust - Rydex Inverse Russell 2000 Etf Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-15 | 2009-06-30 | N-CSRS/A | Wilshire Mutual Funds Inc - Wilshire Small Company Growth Portfolio | Small-Cap Growth | | Sold All | -300 | -100 % | | | | -27.28 % | $1,896 | | | | | | News Article | History of Wilshire Mutual Funds Inc - Wilshire Small Company Growth Portfolio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 2,037,755 | Added More | 73,030 | 3.71 % | $45,849,488 | $34,315,794 | $-11,533,693 | -25.15 % | $-413,350 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Series Funds - Banking Fund | Financial Services | 962 | Sold Some | -180 | -15.76 % | $21,154 | $16,200 | $-4,954 | -23.41 % | $927 | | | | | | News Article | History of Rydex Series Funds - Banking Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust - Biotechnology Fund | Health/Biotech | 11,499 | Sold Some | -5,728 | -33.25 % | $252,863 | $193,643 | $-59,220 | -23.41 % | $29,499 | | | | | | News Article | History of Rydex Variable Trust - Biotechnology Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Universal Institutional Funds Inc - Small Company Growth Portfolio | Small-Cap Growth | 21,553 | Sold Some | -650 | -2.92 % | $473,950 | $362,953 | $-110,998 | -23.41 % | $3,348 | | | | | | News Article | History of Universal Institutional Funds Inc - Small Company Growth Portfolio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Advanced Series Trust - Ast Federated Aggressive Growth Portfolio | Multi-Cap Growth | | Sold All | -56,200 | -100 % | | | | -23.62 % | $292,802 | | | | | | News Article | History of Advanced Series Trust - Ast Federated Aggressive Growth Portfolio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio | Small-Cap Growth | | Sold All | -26,800 | -100 % | | | | -23.62 % | $139,628 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 20,900 | No Change | 0 | 0 % | $460,845 | $351,956 | $-108,889 | -23.62 % | $0 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Value Portfolio | Multi-Cap Value | 6,480 | New Holding | 6,480 | 100 % | $142,884 | $109,123 | $-33,761 | -23.62 % | $-33,761 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Value Portfolio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqbond Index Portfolio | Specialty & Misc | 68,940 | Added More | 19,040 | 38.15 % | $1,520,127 | $1,160,950 | $-359,177 | -23.62 % | $-99,198 | | | | | | News Article | History of Eq Advisors Trust - Eqbond Index Portfolio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Massmutual Select Funds - Massmutual Select Small Company Growth Fund | Small-Cap Growth | 4,292 | Added More | 280 | 6.97 % | $94,639 | $72,277 | $-22,361 | -23.62 % | $-1,459 | | | | | | News Article | History of Massmutual Select Funds - Massmutual Select Small Company Growth Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Morgan Stanley Institutional Fund Inc - Small Company Growth Portfolio | Small-Cap Growth | 877,300 | Sold Some | -23,486 | -2.60 % | $19,344,465 | $14,773,732 | $-4,570,733 | -23.62 % | $122,362 | | | | | | News Article | History of Morgan Stanley Institutional Fund Inc - Small Company Growth Portfolio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Bull Profund | Large-Cap Core | | Sold All | -2,256 | -100 % | | | | -23.62 % | $11,754 | | | | | | News Article | History of Profunds - Bull Profund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 2,010 | Sold Some | -390 | -16.25 % | $44,321 | $33,848 | $-10,472 | -23.62 % | $2,032 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Institutional Index Funds - Vanguard Institutional Index Fund | Specialty & Misc | 31,850 | New Holding | 31,850 | 100 % | $702,293 | $536,354 | $-165,939 | -23.62 % | $-165,939 | | | | | | News Article | History of Vanguard Institutional Index Funds - Vanguard Institutional Index Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Variable Insurance Funds - Small Company Growth Portfolio | Small-Cap Growth | 17,000 | New Holding | 17,000 | 100 % | $374,850 | $286,280 | $-88,570 | -23.62 % | $-88,570 | | | | | | News Article | History of Vanguard Variable Insurance Funds - Small Company Growth Portfolio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Advisors Series Trust - Capital Advisors Growth Fund | Multi-Cap Growth | 11,100 | New Holding | 11,100 | 100 % | | $186,924 | | - % | | | | | | | News Article | History of Advisors Series Trust - Capital Advisors Growth Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | American Century Quantitative Equity Funds Inc - Utilities Fund | Utility | | Sold All | -21,379 | -100 % | | | | - % | | | | | | | News Article | History of American Century Quantitative Equity Funds Inc - Utilities Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund Ii - Mml Small Cap Equity Fund | Small-Cap Core | 1,770 | Added More | 410 | 30.14 % | | $29,807 | | - % | | | | | | | News Article | History of Mml Series Investment Fund Ii - Mml Small Cap Equity Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | New Covenant Funds - New Covenant Growth Fund | No Data | | Sold All | -2,290 | -100 % | | | | - % | | | | | | | News Article | History of New Covenant Funds - New Covenant Growth Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pd Small-Cap Growth Index Portfolio | No Data | 618 | No Compare | | | | $10,407 | | - % | | | | | | | News Article | History of Pacific Select Fund - Pd Small-Cap Growth Index Portfolio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Small-Cap Index Portfolio | No Data | 19,055 | New Holding | 19,055 | 100 % | | $320,886 | | - % | | | | | | | News Article | History of Pacific Select Fund - Small-Cap Index Portfolio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | Streettracks Series Trust - Spdr Dividend Etf | Specialty & Misc | | Sold All | -991,020 | -100 % | | | | - % | | | | | | | News Article | History of Streettracks Series Trust - Spdr Dividend Etf Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Amvescap Plc | Institution | 18,787 | Sold Some | -33,555 | -64.10 % | $410,308 | $316,373 | $-93,935 | -22.89 % | $167,775 | | | | | | News Article | History of Amvescap Plc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fmr Corp | Institution | 6,247,808 | Sold Some | -26,100 | -0.41 % | $136,452,127 | $105,213,087 | $-31,239,040 | -22.89 % | $130,500 | | | | | | News Article | History of Fmr Corp Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | N-Q/A | Rydex Series Funds - Biotechnology Fund | Health/Biotech | 72,338 | Added More | 17,720 | 32.44 % | $1,579,862 | $1,218,172 | $-361,690 | -22.89 % | $-88,600 | | | | | | News Article | History of Rydex Series Funds - Biotechnology Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Fidelity Central Investment Portfolios Llc - Fidelity Health Care | Health/Biotech | 72,063 | No Change | 0 | 0 % | $1,607,005 | $1,213,541 | $-393,464 | -24.48 % | $0 | | | | | | News Article | History of Fidelity Central Investment Portfolios Llc - Fidelity Health Care Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Fidelity Destiny Portfolios - Diversified Stock Fund | Large-Cap Growth | 405,000 | No Change | 0 | 0 % | $9,031,500 | $6,820,200 | $-2,211,300 | -24.48 % | $0 | | | | | | News Article | History of Fidelity Destiny Portfolios - Diversified Stock Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Mutual Of America Investment Corp - Bond Fund | Specialty & Misc | 27,631 | Sold Some | -6,563 | -19.19 % | $616,171 | $465,306 | $-150,865 | -24.48 % | $35,834 | | | | | | News Article | History of Mutual Of America Investment Corp - Bond Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Stock Index Fund | Specialty & Misc | 434 | Added More | 90 | 26.16 % | $9,678 | $7,309 | $-2,370 | -24.48 % | $-491 | | | | | | News Article | History of Tiaa Cref Life Fund - Stock Index Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Usaa Mutual Funds Trust - Value Fund | Multi-Cap Value | 12,500 | New Holding | 12,500 | 100 % | $278,750 | $210,500 | $-68,250 | -24.48 % | $-68,250 | | | | | | News Article | History of Usaa Mutual Funds Trust - Value Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Nasdaq Biotechnology Index Fund | Health/Biotech | 370,735 | Sold Some | -22,102 | -5.62 % | $8,323,001 | $6,243,177 | $-2,079,823 | -24.98 % | $123,992 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Growth Index Fund | Multi-Cap Growth | 255,115 | Added More | 13,768 | 5.70 % | $5,727,332 | $4,296,137 | $-1,431,195 | -24.98 % | $-77,238 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Growth Index Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Index Fund | Specialty & Misc | 434,462 | Sold Some | -5,590 | -1.27 % | $9,753,672 | $7,316,340 | $-2,437,332 | -24.98 % | $31,360 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Index Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | 2,308 | Sold Some | -5 | -0.21 % | $51,815 | $38,867 | $-12,948 | -24.98 % | $28 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Growth Index Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Index Fund | Specialty & Misc | 10,466 | Added More | 600 | 6.08 % | $234,962 | $176,247 | $-58,714 | -24.98 % | $-3,366 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Index Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Seasons Series Trust - Stock Portfolio | Multi-Cap Core | 1,223 | New Holding | 1,223 | 100 % | $27,456 | $20,595 | $-6,861 | -24.98 % | $-6,861 | | | | | | News Article | History of Seasons Series Trust - Stock Portfolio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Value Line Emerging Opportunities Fund Inc - Value Line Emerging Opportunities Fund Inc | Small-Cap Growth | 31,000 | No Change | 0 | 0 % | $695,950 | $522,040 | $-173,910 | -24.98 % | $0 | | | | | | News Article | History of Value Line Emerging Opportunities Fund Inc - Value Line Emerging Opportunities Fund Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | 310,345 | Sold Some | -99,679 | -24.31 % | $6,967,245 | $5,226,210 | $-1,741,035 | -24.98 % | $559,199 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Fidelity Trend Fund - Fidelity Trend Fund | Large-Cap Core | 52,200 | No Change | 0 | 0 % | $1,214,172 | $879,048 | $-335,124 | -27.60 % | $0 | | | | | | News Article | History of Fidelity Trend Fund - Fidelity Trend Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Leuthold Funds Inc - Leuthold Core Investment Fund | Flexible Portfolio | 123,027 | New Holding | 123,027 | 100 % | $2,861,608 | $2,071,775 | $-789,833 | -27.60 % | $-789,833 | | | | | | News Article | History of Leuthold Funds Inc - Leuthold Core Investment Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Leuthold Funds Inc - Leuthold Select Industries Fund | Specialty Dvsfd Eq | 7,465 | New Holding | 7,465 | 100 % | $173,636 | $125,711 | $-47,925 | -27.60 % | $-47,925 | | | | | | News Article | History of Leuthold Funds Inc - Leuthold Select Industries Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Equity Index Fund | Specialty & Misc | 24,335 | Added More | 15,536 | 176.56 % | $566,032 | $409,801 | $-156,231 | -27.60 % | $-99,741 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Equity Index Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Growth Equity Fund | Multi-Cap Growth | | Sold All | -12,741 | -100 % | | | | -27.60 % | $81,797 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Growth Equity Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard 500 Index Fund | S&P 500 Index | | Sold All | -582,376 | -100 % | | | | -27.60 % | $3,738,854 | | | | | | News Article | History of Vanguard Index Funds - Vanguard 500 Index Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Extended Market Index Fund | Mid-Cap Core | 220,209 | New Holding | 220,209 | 100 % | $5,122,061 | $3,708,320 | $-1,413,742 | -27.60 % | $-1,413,742 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Extended Market Index Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Growth Index Fund | Large-Cap Growth | 271,691 | New Holding | 271,691 | 100 % | $6,319,533 | $4,575,276 | $-1,744,256 | -27.60 % | $-1,744,256 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Growth Index Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Total Stock Market Index Fund | Multi-Cap Core | 328,669 | Added More | 26,839 | 8.89 % | $7,644,841 | $5,534,786 | $-2,110,055 | -27.60 % | $-172,306 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Total Stock Market Index Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 9,100 | No Change | 0 | 0 % | $211,666 | $153,244 | $-58,422 | -27.60 % | $0 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 16,500 | Added More | 7,400 | 81.31 % | $383,790 | $277,860 | $-105,930 | -27.60 % | $-47,508 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | N-Q | Nicholas Applegate Institutional Funds - International Growth Fund | Multi-Cap Growth | | Sold All | -4,000 | -100 % | | | | -31.43 % | $30,880 | | | | | | News Article | History of Nicholas Applegate Institutional Funds - International Growth Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | N-Q | Oppenheimer Global Opportunities Fund - Oppenheimer Global Opportunities Fund | Global Flex Port | | Sold All | -1,200,000 | -100 % | | | | -31.43 % | $9,264,000 | | | | | | News Article | History of Oppenheimer Global Opportunities Fund - Oppenheimer Global Opportunities Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-CSRS | Alliancebernstein Variable Products Series Fund Inc - Alliancebernstein Growth Portfolio | Multi-Cap Growth | 39,200 | New Holding | 39,200 | 100 % | $944,328 | $660,128 | $-284,200 | -30.09 % | $-284,200 | | | | | | News Article | History of Alliancebernstein Variable Products Series Fund Inc - Alliancebernstein Growth Portfolio Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | 13F-HR | Mcmillion Capital Management Inc | Institution | 50 | No Change | 0 | 0 % | $1,205 | $842 | $-363 | -30.09 % | $0 | | | | | | News Article | History of Mcmillion Capital Management Inc Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-Q | Mellon Institutional Funds Investment Trust - The Boston Company International Small Cap Fund | Small-Cap Core | | Sold All | -52,320 | -100 % | | | | -30.09 % | $379,320 | | | | | | News Article | History of Mellon Institutional Funds Investment Trust - The Boston Company International Small Cap Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-Q | Mellon Institutional Funds Investment Trust - The Boston Company Small Cap Growth Fund | Small-Cap Growth | 73,940 | New Holding | 73,940 | 100 % | $1,781,215 | $1,245,150 | $-536,065 | -30.09 % | $-536,065 | | | | | | News Article | History of Mellon Institutional Funds Investment Trust - The Boston Company Small Cap Growth Fund Ownership Of Alnylam Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-CSRS | Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva | Specialty & Misc | 10,100 | New Holding | 10,100 | 100 % | $243,309 | $170,084 | $-73,225 | -30.09 % | $-73,225 | | | | | | News Article | History of Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva Ownership Of Alnylam Pharmaceuticals Inc |
RSS feed for ALNY